Tolerability of partially and extensively hydrolysed milk formulas in children with cow's milk allergy

Chisato Inuo1,2,3, Kenichi Tanaka2, Yoichi Nakajima4

  • 1Department of Pediatrics, School of Medicine, Fujita Health University, Toyoake, Japan. inuo@mbh.nifty.com.

Insights

Partially and extensively hydrolyzed formulas are safer for children with cow's milk allergy (CMA) compared to regular cow's milk formula. These hydrolyzed formulas show better tolerability in children diagnosed with CMA.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Nutrition
  • Gastroenterology

Background:

  • Cow's milk allergy (CMA) is a common condition in infants and children.
  • The safety and tolerability of hydrolyzed formulas for CMA management require further investigation.
  • Partially hydrolyzed formulas (pHFs) are often used, but their efficacy in CMA is not fully established.

Purpose of the Study:

  • To evaluate the tolerability of different types of hydrolyzed cow's milk protein-based formulas in children with diagnosed CMA.
  • To compare the allergic tolerance to partially hydrolyzed formula (pHF), extensively hydrolyzed formula (eHF), and regular cow's milk formula (rCMF).

Main Methods:

  • A three-period, double-blind, crossover study design was employed.
  • Twenty-five children diagnosed with CMA underwent controlled food challenges with eHF, pHF, and rCMF.
  • The primary outcome measured was the rate of tolerance to a 20.0 mL formula challenge.

Main Results:

  • Children with CMA demonstrated significantly higher tolerance rates to pHF (16/25) and eHF (22/25) compared to rCMF (2/25).
  • Allergic symptom scores were significantly lower for both pHF and eHF when compared to rCMF.
  • No significant difference in symptom scores was observed between pHF and eHF.

Conclusions:

  • Partially and extensively hydrolyzed formulas are better tolerated and safer than regular cow's milk formula for children with CMA.
  • pHFs may be considered for children with mild CMA, pending further multi-center confirmation.
  • Caution is advised with food challenge tests for hydrolyzed formulas in children with CMA due to potential reactions.
Abstract

Related Concept Videos

Hydrolysis01:15

Hydrolysis

Overview
Hydrolysis is a chemical reaction in which the addition of water breaks down a polymer into its simpler monomer units. For example, peptides break into amino acids, carbohydrates into simple sugars, and DNA into nucleotides. Enzymes often facilitate these processes.
Hydrolysis Reverses Dehydration Synthesis
Complex carbohydrates can be broken down by breaking the bonds between individual sugar units. The reaction breaks a glycosidic bond as water is added to the compound. The...
Allergic Reactions02:06

Allergic Reactions

Overview
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...